Cargando…

Covalent targeting as a common mechanism for inhibiting NLRP3 inflammasome assembly

The NLRP3 inflammasome is a cytosolic protein complex important for the regulation and secretion of inflammatory cytokines including IL-1β and IL-18. Aberrant overactivation of NLRP3 is implicated in numerous inflammatory disorders. However, the activation and regulation of NLRP3 inflammasome signal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanton, Caroline, Sun, Jie, Nutsch, Kayla, Rosarda, Jessica D., Nguyen, Thu, Li-Ma, Chloris, Kutseikin, Sergei, Saez, Enrique, Teijaro, John R., Wiseman, R. Luke, Bollong, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312593/ https://www.ncbi.nlm.nih.gov/pubmed/37398499 http://dx.doi.org/10.1101/2023.06.01.543248

Ejemplares similares

Succinylation of a KEAP1 sensor lysine promotes NRF2 activation
por: Ibrahim, Lara, et al.
Publicado: (2023)

Metabolically Activated Proteostasis Regulators Protect against Glutamate Toxicity by Activating NRF2
por: Rosarda, Jessica D., et al.
Publicado: (2021)

A covalent inhibitor of the YAP–TEAD transcriptional complex identified by high-throughput screening
por: Nutsch, Kayla, et al.
Publicado: (2023)

Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
por: He, Hongbin, et al.
Publicado: (2018)

S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling
por: Ko, Yeonjin, et al.
Publicado: (2023)

Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases
por: Xu, Haowen, et al.
Publicado: (2023)

NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
por: Stutz, Andrea, et al.
Publicado: (2017)

Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells
por: Zhou, Xiangyu, et al.
Publicado: (2017)

Right place, right time: localisation and assembly of the NLRP3 inflammasome
por: Hamilton, Claire, et al.
Publicado: (2019)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

NLRP3, the inflammasome and COVID-19 infection
por: Yin, Maureen, et al.
Publicado: (2023)

The NLRP1 and CARD8 inflammasomes
por: Taabazuing, Cornelius Y., et al.
Publicado: (2020)

The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation
por: Rodgers, Mary A., et al.
Publicado: (2014)

NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly
por: Niu, Tingting, et al.
Publicado: (2021)

The role of the NLRP3 inflammasome in gout
por: Kingsbury, Sarah R, et al.
Publicado: (2011)

WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
por: Batiha, Gaber El-Saber, et al.
Publicado: (2021)

NLRP3 Inflammasome Activation in Peripheral Arterial Disease
por: Bartoli‐Leonard, Francesca, et al.
Publicado: (2023)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Targeting the NLRP3 Inflammasome via BTK
por: Weber, Alexander N. R.
Publicado: (2021)

Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8
por: Gong, Qin, et al.
Publicado: (2021)

L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis
por: Joshi, Hemant, et al.
Publicado: (2022)

Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases
por: Paget, Christophe, et al.
Publicado: (2022)

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
por: Bulos, Maya L., et al.
Publicado: (2023)

Role of the Nlrp3 Inflammasome in Microbial Infection
por: Anand, Paras K., et al.
Publicado: (2011)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

Vimentin regulates activation of the NLRP3 inflammasome
por: dos Santos, Gimena, et al.
Publicado: (2015)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation
por: Xian, Hongxu, et al.
Publicado: (2021)

The Role of the NLRP3 Inflammasome in Fibrosis
por: Artlett, Carol M
Publicado: (2012)

NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013)

NLRP3 Inflammasome and Pathobiology in AMD
por: Celkova, Lucia, et al.
Publicado: (2015)

Role of the NLRP3 inflammasome in cancer
por: Moossavi, Maryam, et al.
Publicado: (2018)

Spotlight on the NLRP3 inflammasome pathway
por: Groslambert, Marine, et al.
Publicado: (2018)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oss19o4gje9fcfhmthb86vgl8h